A Frizzled4-LRP5 agonist promotes blood-retina barrier function by inducing a Norrin-like transcriptional response

被引:4
作者
Zhang, Lingling [1 ]
Abedin, Md. [1 ]
Jo, Ha-Neul [1 ,2 ]
Levey, Jacklyn [1 ,2 ]
Dinh, Quynh Chau [1 ]
Chen, Zhe [3 ]
Angers, Stephane [4 ,5 ,6 ]
Junge, Harald J. [1 ,2 ]
机构
[1] Univ Minnesota, Dept Ophthalmol & Visual Neurosci, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Grad Program Mol Cellular Dev Biol & Genet, Minneapolis, MN 55455 USA
[3] Univ Minnesota, Dept Neurosci, Minneapolis, MN USA
[4] Univ Toronto, Dept Biochem, Toronto, ON, Canada
[5] Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada
[6] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada
基金
加拿大健康研究院;
关键词
BRAIN-BARRIER; CANONICAL WNT; VASCULAR DEVELOPMENT; DISEASE; GPR124; CNS; ANGIOGENESIS; TSPAN12; INTEGRITY; SURROGATE;
D O I
10.1016/j.isci.2023.107415
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Norrin (NDP) and WNT7A/B induce and maintain the blood-brain and blood -retina barrier (BBB, BRB) by stimulating the Frizzled4-LDL receptor related pro-tein 5/6 (FZD4-LRP5/6) complex to induce beta-catenin-dependent signaling in endothelial cells (ECs). Recently developed agonists for the FZD4-LRP5 complex have therapeutic potential in retinal and neurological diseases. Here, we use the tetravalent antibody modality F4L5.13 to identify agonist activities in Tspan12-/- mice, which display a complex retinal pathology due to impaired NDP-signaling. F4L5.13 administration during development alleviates BRB de-fects, retinal hypovascularization, and restores neural function. In mature Tspan12-/- mice F4L5.13 partially induces a BRB de novo without inducing angio-genesis. In a genetic model of impaired BRB maintenance, administration of F4L5.13 rapidly and substantially restores the BRB. scRNA-seq reveals perturba-tions of key mediators of barrier functions in juvenile Tspan12-/- mice, which are in large parts restored after F4L5.13 administration. This study identifies tran-scriptional and functional activities of FZD4-LRP5 agonists.
引用
收藏
页数:20
相关论文
empty
未找到相关数据